glp 1 agonist history Glucagon-like peptide-1 receptor: mechanisms and advances in therapy What are GLP-1s? | Mendinground

Side effects that do not resolve Tirzepatide works

Back Bloom, A (11 Nov 2024) 'Weight loss injections and cancer: 6 questions, answered', MD Anderson Cancer Center

Liraglutide Liraglutide was approved in December 2020 for weight management in adolescents aged 12 and older with a body weight above 60 kg and an initial BMI corresponding to 30 kg/m or greater for adults

Secondary analysis of renal end points in a cardiovascular safety trial of a DPP-4 inhibitor in patients with T2DM at high cardiovascular risk, showing that saxagliptin reduces albuminuria in a glucose-independent manner

That would be expected, given that obesity and excess weight are risk factors for heart attack and stroke